Investors & Media

Corporate Profile

Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases.

Our MPPs are selectively-sized nanoparticles and have proprietary coatings. We believe that these two key attributes enable even distribution of drug particles on mucosal surfaces and significantly increase drug delivery to target tissues by enhancing mobility of drug particles through mucus and preventing drug particles from becoming trapped and eliminated by mucus.

Read More »

Stock Quote KALA (Common Stock) $18.04 + 0.14 (0.78%)
ExchangeNASDAQ GS
Volume215,125
Today's Open$17.77
Previous Close$17.90
Data as of 12/12/17 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: KALA.O.  Currently trading at $18.04 with a 52 week high of $26.75 and a 52 week low of $13.51.
Latest News
Latest Events
There are currently no events scheduled.

Read More »